The protein expression levels of activated insulin receptor substrate 1 (IRS1) and activated protein kinase B (AKT), markers of insulin resistance, were decreased in GLcN-treated cells, while they were increased by NaB treatment in a dose-dependent manner, although there were no statistically significant differences in AKT (Fig. 6C). The gene discussed is AKT1; the disease is Insulin resistance.